Clinical-Epidemiological Program of Studying Psychosocial Risk Factors in Cardiological Practice in Patients With Arterial Hypertension and Ischemic Heart Disease: First Results of a Multicenter Study in Russia

Background. More than 10 years passed since conduction of the first clinical-epidemiological study of prevalence of psychosocial risk factors (PSRF) in patients with arterial hypertension (AH) an/or ischemic heart disease in Russian Federation. Purpose: to assess current prevalence of PSRF in patients with AH/CHD and their relationship with traditional risk factors. Materials and methods. Patients with verified AH and/or CHD aged ≥55 years were included into this cross-sectional study in 30 cities of Russia representing 7 federal districts according to the following procedure. In each city we selected 2-5 federal clinics - providers of primary medical care; in each of these clinics we at random invited 2-5 physicians to take part in this study. Each of these physicians for 1-2 days included 10 consecutive patients with AH and/ or CHD. Information collected from patients comprised social demographic and clinical characteristics, risk factors, adherence to therapy; Hospital Anxiety and Depression Scale (HADS) was applied for detection of symptoms of anxiety and depression. Obtained information was used for analysis of prevalence of cardiovascular risk factors and their association with symptoms of depression and anxiety in a framework of Pearson linear and Kendall rank correlation analysis. Results. Symptoms of anxiety of various severity (HADS-A≥7) were detected in 42.2% of patients with AH and/or CHD, in 25.5% they were clinically significant (HADS-A>11). Symptoms of depression of various severity (HADS-D ≥7) were detected in 42.5% of patients with AH and/or CHD, in 16.3% they were clinically significant (HADS-D≥11). We also observed several significant associations of symptoms ofdepression and anxiety with traditional cardiovascular risk factors: low level of physical activity, elevated systolic and diastolic arterial pressure, level of total cholesterol, abdominal obesity; some unhealthy nutritional habits. Conclusions. Prevalence of symptoms of anxiety and depression was found to be high among ambulatory patients with AH and/or CHD. However, in this study it was lower compared with that reported by previous studies in Russia.

артериальная гипертония, ишемическая болезнь сердца, депрессия, тревожность, психосоциальные факторы риска, hypertension, ischemic heart disease, depression, anxiety, psychosocial risk factors

1. Piepoli M. F., Hoes A. W., Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37 (29):2315-2381. DOI: 10.1093/eurheartj/ehw106. Epub 2016 May 23.

2. Бойцов С. А., Погосова Н. В. и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал 2018; 23 (6): 7-122

3. Pogosova N., Saner H., Pedersen S. S. et al. Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J. Prev Cardiol 2015; 22 (10):1290-1306.

4. De Miranda Azevedo R., Roest A. M., Hoen P. W. et al. Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: A meta-analysis. Psychol Med 2014;27:1-15.

5. Kamphuis M. H., Kalmijn S., Tijhuis M. A. R. et al. Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (Fine) study. European Journal of Cardiovascular Prevention & Rehabilitation 2006;13:199-206.

6. Parakh K., Thombs B. D., Fauerbach J. A. et al. Effect of depression on late (8 years) mortality after myocardial infarction. Am J. Cardiol 2008;101:602-606.

7. Grace S. L., Abbey S. E., Kapral M. K. et al. Effect of depression on five-year mortality after an acute coronary syndrome. Am J. Cardiol 2005;96:1179-1185.

8. Gan Y., Gong Y., Tong X. et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14:371.

9. van Dijk M. R., Utens E. M., Dulfer K. et al. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up. Eur J. Prevent Cardiol 2015;0 (00) 1-7. DOI: 10.1177/2047487315571889.

10. May H. T., Horne B. D., Knight S. et al. The association of depression at any time to the risk of death following coronary artery disease diagnosis. Eur Heart J. Qual Clin Outcomes 2017; DOI:10.1093/ehjqcco/qcx017.

11. Погосова Н. В., Колтунов И. Е., Юферева Ю. М. Тревожные расстройства в кардиологической практике: состояние проблемы. Российский кардиологический журнал 2010;5:98-102

12. Van Melle J. P., de Jonge P., Honig A., et al. Effects of antidepressant treatment following myocardial infarction. Br J. Psychiatry 2007;190:460-466.

13. Roest A. M., Martens E.J., Denollet J. et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom Med 2010;72:563-569.

14. Погосова Г. В. Депрессия - фактор риска развития ишемической болезни сердца и предиктор коронарной смерти: 10 лет научного поиска. Кардиология 2012;52 (12):4-11

15. Glassman A. H., O'Connor C. M., Califf R. M. et al. Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288 (6):701-709.

16. Connerney I., Sloan R. P., Shapiro P. A. et al. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010;72:874-881.

17. Lesperance F., Frasure-Smith N., Talajic M. et al. Five year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049-1053.

18. Carney R. M., Freedland K. E. Depression in patients with coronary artery disease: A more significant problem than previously recognized? Eur Heart J. Qual Clin Outcomes 2017; DOI:10.1093/ ehj qcco / qcx019.

19. Чазов Е. И., Оганов Р. Г., Погосова Г. В. и др. Клинико-эпидемиологическая программа изучения депрессии в кардиологической практике у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): результаты многоцентрового исследования. Кардиология 2007;3:28-37

20. Оганов Р. Г., Погосова Г. В., Колтунов И. Е. и соавт. Депрессивная симптоматика ухудшает прогноз сердечно-сосудистых заболеваний и снижает продолжительность жизни больных артериальной гипертонией и ишемической болезнью сердца. Кардиология 2011;2:59-66

21. Zigmond A. S., Snaith R. P. Hospital Anxiety and Depression Scale. Acta Psychiat Scand 1983;67:361-370.

22. Shulman K. I., Gold D. P., Cohen C. A., Zucchero C. A.: Clock-drawing and dementia in the community: a longitudinal study. Int J. Geriatr Psychiatry 1993;8:487-496.

23. World Health Organization. Women's mental health: an evidence based review. Geneva: World Health Organization; 2000. Report no.: WHO/MSD/MDP/00.12000: 47.

24. Huffman J. C., Celano C. M., Beach S. R. et al. Depression and Cardiac Disease: Epidemiology, Mechanisms, and Diagnosis. Cardiovasc Psychiatry Neurol 2013;2013: 695925.

25. Lichtman J. H., Bigger Jr J. T., Blumenthal J. A. et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768-1775.

26. Погосова Г. В., Колтунов И. Е., Соколова О. Ю. Вторичная профилактика артериальной гипертонии и ише мической болезни сердца в реальной клинической практике Российской Федерации. Москва, «Викас-принт» 2009, 35-36 с.

27. Погосова Н. В., Оганов Р. Г., Бойцов С. А. и др. Психосоциальные факторы и качество жизни у пациентов с ишемической болезнью сердца: результаты российской части международного многоцентрового исследования EUROASPIRE IV. Кардиоваскулярная терапия и профилактика 2017;16 (5):20-26

28. Gehi A., Haas D., Pipkin S., Whooley M. A. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005;165:2508-2513. DOI: 10.1001/ archinte. 165.21.2508.

29. Ruo B., Rumsfeld J. S., Pipkin S., Whooley M. A. Relation between depressive symptoms and treadmill exercise capacity in the Heart and Soul Study. Am J. Cardiol 2004;94:96-99. DOI: 10.1016/ j.amjcard. 2004.03.035.

30. Whooley M. A., de Jonge P., Vittinghoff E. et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379-2388. DOI: 10.1001/jama. 2008.711.

31. Rutledge T., Kenkre T. S., Thompson D. V. et al. Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia. Am J. Med 2014;127:840-847. DOI: 10.1016/j.amjmed. 2014.04.011.